Diabetes, pancreatogenic diabetes, and pancreatic cancer

Andersen, Dana K., Korc, Murray, Petersen, Gloria M., Eibl, Guido, Li, Donghui, Rickels, Michael R., Chari, Suresh T., Abbruzzese, James L.·2017·Diabetes

Cited by (525)

Items 101–200 of 525

  1. Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
    Rong Tang, Xiaomeng Liu, Wei Wang, Jie Hua, Jin Xu, Chen Liang, Qingcai Meng, Jiang Liu, Bo Zhang, Xianjun Yu et al. · 2021 · Cancer Cell International
  2. Clinical Prediction Models for Pancreatic Cancer in General and At-Risk Populations: A Systematic Review
    Ralph J. Santos, Helen G. Coleman, Victoria Cairnduff, Andrew T. Kunzmann · 2022 · The American Journal of Gastroenterology
  3. A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer
    Khemayanto Hidayat, Ying‐Yi Zhou, Hong‐Zhen Du, Li‐Qiang Qin, Bimin Shi, Zeng‐Ning Li · 2022 · Pharmacoepidemiology and Drug Safety
  4. Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment
    Chien‐Chi Lin, Murray Korc · 2018 · Cancer Letters
  5. Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population
    Liqi Sun, Yang Wang, Fei Jiang, Wei Qian, Chengwei Shao, Zhendong Jin · 2019 · Journal of Gastroenterology and Hepatology
  6. Neural innervation in adipose tissue, gut, pancreas, and liver
    Mengxue Sun, Yongwen Wan, Mengjie Shi, Zhuo‐Xian Meng, Wenwen Zeng · 2023 · Life Metabolism
  7. Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitis
    Maisam A. Abu‐El‐Haija, Lindsey N. Hornung, Lee A. Denson, Ammar Husami, Tom K. Lin, Kristal Anne Matlock, Jaimie D. Nathan, Joseph J. Palermo, Tyler Thompson, C. Alexander Valencia et al. · 2018 · PLoS ONE
  8. Uncovering the relationship and mechanisms of Tartary buckwheat ( Fagopyrum tataricum ) and Type II diabetes, hypertension, and hyperlipidemia using a network pharmacology approach
    Chaolong Lu, Qi Zheng, Qi Shen, Chi Song, Zhiming Zhang · 2017 · PeerJ
  9. Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders
    Arianna Scuteri, Marianna Monfrini · 2018 · International Journal of Molecular Sciences
  10. Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms
    Marta Sandini, Oliver Strobel, Thomas P. Hank, Magdalena Lewosinska, Anna Nießen, Thilo Hackert, Markus Wolfgang Büchler, Simon J. Schimmack · 2019 · Surgery
  11. Transforming growth factor‐β signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?
    MA Xing-yuan, Zhiwei Cui, Zhide Du, Hui Lin · 2020 · Journal of Cellular Physiology
  12. Insulin resistance and cancer: molecular links and clinical perspectives
    Alfredo Caturano, Enes Erul, Roberto Nilo, Davide Nilo, Vincenzo Russo, Luca Rinaldi, Carlo Acierno, Maria Teresa Gemelli, Riccardo Ricotta, Ferdinando Carlo Sasso et al. · 2025 · Molecular and Cellular Biochemistry
  13. Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases
    Kailin Li, Yao Xiao, Ji Bian, Lin Han, Caian He, Emad M. El-Omar, Lan Gong, Min Wang · 2022 · Nutrients
  14. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study
    Pui San Tan, César Garriga, Ashley Kieran Clift, Weiqi Liao, Martina Patone, Carol A. C. Coupland, Rachael J. M. Bashford-Rogers, Shivan Sivakumar, Julia Hippisley‐Cox · 2022 · Gut
  15. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer
    Bechien U. Wu, Rebecca K. Butler, Eva Lustigova, Jean M. Lawrence, Wansu Chen · 2020 · JAMA Network Open
  16. A systematic study of novel drug delivery mechanisms and treatment strategies for pancreatic cancer
    Umme Hani, Riyaz Ali M. Osmani, Ayesha Siddiqua, Shadma Wahab, Sadia Batool, Hissana Ather, Norhan S. Sheraba, Ali Alqahtani · 2021 · Journal of Drug Delivery Science and Technology
  17. Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery
    Shuhei Shinoda, Naohiko Nakamura, Brett Roach, David Bernlohr, Sayeed Ikramuddin, Masato Yamamoto · 2022 · Biomedicines
  18. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
    Geou‐Yarh Liou, Crystal J. Byrd · 2023 · Cancers
  19. Challenges of Managing Type 3c Diabetes in the Context of Pancreatic Resection, Cancer and Trauma
    Colton D. Wayne, Chahrazed Benbetka, Gail Ellen Besner, Siddharth Narayanan · 2024 · Journal of Clinical Medicine
  20. Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990–2019
    Haoran Zhao, Yubao Zhang, Haishi Liu, Yunfeng Wang, Zengfu Song · 2024 · BMC Cancer
  21. Chiroptical spectroscopy and metabolomics for blood‐based sensing of pancreatic cancer
    Lucie Habartová, Bohuš Bunganič, Michal Tatarkovič, Miroslav Zavoral, Jana Vondroušová, Kamila Syslová, Vladimı́r Setnička · 2018 · Chirality
  22. Association between alcohol consumption and pancreatic cancer risk differs by glycaemic status: A nationwide cohort study
    Joo‐Hyun Park, Kyungdo Han, Jung Yong Hong, Young Suk Park, Joon Oh Park · 2022 · European Journal of Cancer
  23. Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance
    Jiantong Bao, Dechen Liu, Jinfang Sun, Xianghui Su, Hao Cheng, Liang Qi, Yidi Zhang, Yingqi Lv, Ye Zheng, Xuebing Yu et al. · 2022 · Diabetes Research and Clinical Practice
  24. Risk factors and nomogram for diabetes mellitus in idiopathic chronic pancreatitis
    Yu Liu, Dan Wang, Hong‐Lei Guo, Lu Hao, Teng Wang, Di Zhang, Huai‐Yu Yang, Jia‐Yi Ma, Juan Li, Lingling Zhang et al. · 2019 · Journal of Gastroenterology and Hepatology
  25. Diabetes risk reduction diet and the risk of pancreatic cancer
    Federica Turati, Marta Rossi, Veronica Mattioli, Francesca Bravi, Eva Negri, Carlo La Vecchia · 2021 · European Journal of Nutrition
  26. Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects
    Byung Kyu Park, Jeong Hun Seo, Jae Bock Chung, Jung Kyu Choi · 2022 · British Journal of Cancer
  27. High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment
    Chenggang Gao, Jiaoshun Chen, Jianwei Bai, Haoxiang Zhang, Yanyi Tao, Shihong Wu, Hehe Li, Heshui Wu, Qiang Shen, Tao Yin · 2023 · Journal of Translational Medicine
  28. The role of biomarkers in the early detection of pancreatic cancer
    Michael Goggins · 2024 · Familial Cancer
  29. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients
    Sandra Ueberberg, Michael Albrecht Nauck, Waldemar H. Uhl, Chiara Montemurro, Andrea Tannapfel, Anne Clark, Juris Jendrik Meier · 2020 · The Journal of Clinical Endocrinology & Metabolism
  30. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells
    Juichiro Yoshida, Takeshi Ishikawa, Yuki Endo, Shinya Matsumura, Takayuki Ota, Katsura Mizushima, Yasuko Hirai, Kaname Oka, Tetsuya Okayama, Naoyuki Sakamoto et al. · 2020 · Oncology Reports
  31. Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity
    Bertrand Duvillié, Rayane Kourdoughli, Sabine Druillennec, Alain Eychène, Célio Pouponnot · 2020 · Frontiers in Endocrinology
  32. Obesity-Associated Cancers: Evidence from Studies in Mouse Models
    Ho Lee · 2022 · Cells
  33. Type-2 diabetes mellitus-associated cancer risk: In pursuit of understanding the possible link
    Srinivasa Rao Vulichi, Ashish Runthala, Begari Nagaraju, Rupak Kumar, Venkata Rao Chunduri, Suman Kapur, Appa Rao Chippada, Durga Srinivasa Murthy Sistla · 2022 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  34. Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
    Zhao Liu, Hiromitsu Hayashi, Kazuki Matsumura, Norio Uemura, Yuta Shiraishi, Hiroki Sato, Hideo Baba · 2023 · Cancers
  35. Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models
    Yang Xin Zi Xu, Suresh Mishra · 2018 · Cancers
  36. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
    Enrique Rozengurt, Guido Eibl · 2019 · World Journal of Gastroenterology
  37. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming
    Zhiwei Cai, Li Yang, Mingjian Ma, Longxiang Wang, Hongwei Wang, Meng Liu, Chongyi Jiang · 2023 · Oncology Reports
  38. Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer
    Shashi Anand, Mohammad Aslam Khan, Moh'd M. Khushman, Santanu Dasgupta, Seema Singh, Ajay P. Singh · 2020 · International Journal of Molecular Sciences
  39. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
    Wenjing Song, Xin He, Pengju Gong, Yan T. Yang, Sirui Huang, Yifan Zeng, Lei Wei, Jingwei Zhang · 2021 · Frontiers in Genetics
  40. The Relationship between Diabetes Mellitus and Pancreatic Cancer—Diabetes Mellitus as a Red Flag for Pancreatic Cancer
    Katarina Popovic, Brigita Smolović, Milica Martinović, Ljiljana Vučković · 2023 · Cancer Epidemiology Biomarkers & Prevention
  41. A near-infrared fluorescent probe based FRET for ratiometric sensing of H2O2 and viscosity in live cells
    Fengting Liu, Shuo Wang, Yan-Pu Wang, Pengfei Jiang, Jun‐Ying Miao, Bao‐Xiang Zhao, Zhao‐Min Lin · 2024 · Talanta
  42. Raman spectroscopy and Raman optical activity of blood plasma for differential diagnosis of gastrointestinal cancers
    Kateřina Králová, Ondřej Vrtělka, Markéta Fousková, Petr Hříbek, Bohuš Bunganič, Michaela Miškovičová, Petr Urbánek, Miroslav Zavoral, Lubos B. Petruzelka, Lucie Habartová et al. · 2023 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
  43. Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
    Remya P. G. Ramesh, Hadida Yasmin, Pretty Ponnachan, Basel K. al-Ramadi, Uday Kishore, Ann Mary Joseph · 2025 · Frontiers in Immunology
  44. Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
    Guermarie Velázquez-Torres, Enrique Fuentes‐Mattei, Hyun Ho Choi, Sai‐Ching J. Yeung, Xiangqi Meng, Mong‐Hong Lee · 2020 · Gastroenterology report
  45. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins
    Damiano D. Caputo, Alessandro Coppola, Erica Quagliarini, Riccardo Di Santo, Anna Laura Capriotti, Roberto Cammarata, Aldo Laganà, Massimiliano Papi, Luca Digiacomo, Roberto Coppola et al. · 2022 · Cancers
  46. Risk factors of pancreatic cancer and their possible uses in diagnostics
    Jitka Lang, Lumír Kunovský, Zdeněk Kala, Jan Trna · 2020 · Neoplasma
  47. Interorgan crosstalk in pancreatic islet function and pathology
    Ronald M. Evans, Zong Wei · 2022 · FEBS Letters
  48. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
    Mohamed A Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Gheith O Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim · 2022 · Current Oncology
  49. Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal Samples
    Xiaohan Zhang, Xiuyun Shi, Xin Lu, Yiqun Li, Chao Zhan, Muhammad Luqman Akhtar, Lijun Yang, Yunfan Bai, Jianxiang Zhao, Yu Wang et al. · 2020 · Journal of Cancer
  50. Recent advances in understanding pancreatic cancer
    Martyn Charles Stott, Lucy S. Oldfield, Jessica J. Hale, Eithne Costello, Christopher Michael Halloran · 2022 · Faculty Reviews
  51. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus
    Jan Bureš, Darina Kohoutová, Jan Škrha, Bohuš Bunganič, Ondřej Ngo, Štěpán Suchánek, Pavel Škrha, Miroslav Zavoral · 2023 · Cancers
  52. Atypical Diabetes: What Have We Learned and What Does the Future Hold?
    Stephen Stone, Ashok Balasubramanyam, Jennifer Ellen Posey · 2024 · Diabetes Care
  53. Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus
    Murray Korc · 2019 · Pancreas
  54. SHP2 knockdown ameliorates liver insulin resistance by activating IRS‐2 phosphorylation through the AKT and ERK1/2 signaling pathways
    Xinxin Yue, Tao Han, Wei Hao, Min Wang, Yang Fu · 2020 · FEBS Open Bio
  55. Impact of dietary fat composition and quantity in pancreatic carcinogenesis: Recent advances and controversies
    Joanna Wirkus, Aya Ead, Gerardo Guillermo Mackenzie · 2020 · Nutrition Research
  56. Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory factor-CD44 axis
    Qian Yu, Hui Song, Xiaoya Shi, Liang Zhu, Yu Liang, Ruining Gong, Xiaowu Dong, Shanglong Liu, Hai-zhen Wang, Ying-luo Wang et al. · 2026 · Signal Transduction and Targeted Therapy
  57. Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis
    Jing Xie, Zeye Liu, Liqun Ren, Liyun He, Shan Lü, Xiangzhi Meng, Xin Zhang, Zhanhao Su, Shenqi Jing, Tao Shan et al. · 2023 · BMC Public Health
  58. The Pivotal Role of Macrophages in the Pathogenesis of Pancreatic Diseases
    Seungyeon Ryu, Eun Kyung Lee · 2024 · International Journal of Molecular Sciences
  59. Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review
    Ronald B. Brown · 2019 · Current Diabetes Reviews
  60. Proteostasis Dysregulation in Pancreatic Cancer
    Leena Arpalahti, Caj Haglund, Carina I. Holmberg · 2020 · Advances in experimental medicine and biology
  61. Chronic binge alcohol and ovariectomy-mediated impaired insulin responsiveness in SIV-infected female rhesus macaques
    Liz Simon, Diego Torres, Ari Saravia, Danielle Evé Levitt, Curtis Vande Stouwe, Heather McGarrah, Larry Coleman, Jason Dufour, Angela M. Amedee, Patricia E. Molina · 2021 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  62. The CDK4/6 inhibitor PD0332991 stabilizes FBP1 by repressing MAGED1 expression in pancreatic ductal adenocarcinoma
    Bin Zhang, Dan Li, Xin Jin, Kun Zhang · 2020 · The International Journal of Biochemistry & Cell Biology
  63. Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis
    Alina Ioana Tanțău, Daniel‐Corneliu Leucuta, Marcel Vasile Tantau, Emil Claudiu Botan, Roxana Delia Zaharie, Alina Mândruţiu, Ciprian Tomuleasa · 2020 · Digestive Diseases and Sciences
  64. Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes
    Helen Barong Binang, Chamini Jayamali Perera, Minoti Vivek Apte · 2023 · International Journal of Molecular Sciences
  65. Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study
    Declan McDonnell, A. Cheang, Sam A. Wilding, Sarah H. Wild, Adam Enver Frampton, Christopher D. Byrne, Zaed Z. R. Hamady · 2023 · Cancers
  66. Pancreatic adenocarcinoma protein-protein interaction network analysis.
    Mostafa Rezaei–Tavirani, Sina Rezaei-Tavirani, Nayebali Ahmadi, Nosratollah Naderi, Saeed Abdi · 2017 · PubMed Central
  67. Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype
    Linus Aronsson, Daniel Ansari, Bodil Andersson, Ulf Persson, Adam Fridhammar, Roland E. Andersson · 2018 · HPB
  68. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes
    Roxanne L. Massoumi, Oscar Joe Hines, Guido Eibl, Jonathan C. King · 2018 · Pancreas
  69. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review
    Qun Chen, Wu-Jun Wang, Yun-Xuan Jia, Hao Yuan, Pengfei Wu, Wanli Ge, Lingdong Meng, Xumin Huang, Peng Shen, Taoyue Yang et al. · 2021 · Cell & Bioscience
  70. Healthy lifestyle index and risk of pancreatic cancer in the Women’s Health Initiative
    Rita Peila, Mace Coday, Tracy E. Crane, Nazmus Saquib, Aladdin H. Shadyab, Fred K. Tabung, Xiaochen Zhang, Jean Wactawski‐Wende, Thomas E. Rohan · 2022 · Cancer Causes & Control
  71. Exosomal miR-140–3p and miR-143–3p from TGF-β1-treated pancreatic stellate cells target BCL2 mRNA to increase β-cell apoptosis
    Xiangyun Zhu, Dechen Liu, Guoqing Li, Mengmeng Zhi, Ji Sun, Liang Qi, Jingbo Li, Stephen Jacob Pandol, Ling Li · 2022 · Molecular and Cellular Endocrinology
  72. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
    Lucy S. Oldfield, Martyn Charles Stott, Robert Hanson, Richard Jackson, William F. Reynolds, Vatshala Chandran-Gorner, Robert Van Der Meer, Laurence J. Alison, Ricardo A. Tejeiro, Tejpal Singh Purewal et al. · 2022 · BMJ Open
  73. Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarcinoma
    Guanhua Chen, Chunlu Tan, Xubao Liu, Xing Wang, Qingquan Tan, Yonghua Chen · 2023 · Journal of Clinical Medicine
  74. Trace elements in pancreatic cancer
    Yao Yanjun, Zhuang Jing, Song Yifei, Gu Gangzhao, Yan Chenxin, Qiang Wei, Yan Qiang, Shuwen Han · 2024 · Cancer Medicine
  75. Triglyceride-glucose index and glycemic dynamics in pancreatic ductal adenocarcinoma: implications for disease progression and prognosis
    Yunda Song, Lingmin Jiang, Yuanxia Han, Subo Zhang, Shengping Li · 2024 · Journal of Translational Medicine
  76. Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma—Prevalence, Clinicopathological Variables, and Clinical Outcomes
    Anna Maria Badowska-Kozakiewicz, Marta Magdalena Fudalej, Daria Kwaśniewska, Marek Durlik, Anna Maria Nasierowska-Guttmejer, Agata Mormul, Emilia Włoszek, Aleksandra Izabela Czerw, Tomasz Banaś, Andrzej Deptała · 2022 · Cancers
  77. Chronic Pancreatitis Leading to Pancreatogenic Diabetes Presenting in Diabetic Ketoacidosis: A Rare Entity
    Gabriel Melki, Linda Laham, Gres Karim, Fnu Komal, Vinod Kumar, Shaker Barham, Matthew A. Grossman, Sugabramya Kuru, Hadir Mohamed, Rana Garris et al. · 2019 · Gastroenterology Research
  78. Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer
    Ipek Alpertunga, Rabail Sadiq, Deep S. Pandya, Tammy Lo, Maxim Dulgher, Sarah Evans, Bridget Bennett, Nancy J. Rennert, Richard C. Frank · 2021 · Frontiers in Oncology
  79. Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus
    Liang Qi, Qiong Wei, Muhan Ni, Dechen Liu, Jiantong Bao, Yingqi Lv, Hong Xia, Qian Wang, Lei Wang, Jianhua Su et al. · 2021 · Diabetes & Metabolism
  80. Pre-Existing Psychological Disorders, Diabetes, and Pancreatic Cancer: A Population-Based Study of 38,952 Finns
    Peng Li, Yaoyue Hu, Ghislaine Scélo, Mikko Myrskylä, Pekka Martikainen · 2022 · Cancer Epidemiology
  81. Risk of pancreatic cancer after acute pancreatitis: A population-based matched cohort study
    Byung Kyu Park, Jeong Hun Seo, Kang Ju Son, Jung Kyu Choi · 2023 · Pancreatology
  82. Interlinking of diabetes mellitus and cancer: An overview
    Iftikhar Ahmad, Mohd Suhail, Ausaf Ahmad, Mahmoud Alhosin, Shams S. M. Tabrez · 2023 · Cell Biochemistry and Function
  83. Predicting the risk of pancreatic cancer in women with new‐onset diabetes mellitus
    Sitwat Ali, Michael D Coory, Peter J Donovan, Renhua Na, Nirmala Pandeya, Sallie‐Anne Pearson, Katrina Spilsbury, Karen Tuesley, Susan J. Jordan, Rachel Ε. Neale · 2024 · Journal of Gastroenterology and Hepatology
  84. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990–2019 and projections up to 2040
    Yongguang Wei, Zedong Qin, Xiwen Liao, Xin Zhou, Huasheng Huang, Chenlu Lan, Wei Qin, Guangzhi Zhu, Hao Su, Tao Peng · 2024 · Frontiers in Endocrinology
  85. Development of PDAC diagnosis and prognosis evaluation models based on machine learning
    Yingqi Xiao, Shixin Sun, Naxin Zheng, Jing Zhao, Xiaohan Li, Jianmin Xu, Han Li, Chenran Du, Lijun Zeng, Juling Zhang et al. · 2025 · BMC Cancer
  86. Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
    Hironobu Sasaki, Yoshifumi Saisho, Jun Inaishi, Hiroshi Itoh · 2021 · Journal of the Endocrine Society
  87. Predictors of Disease Progression or Performance Status Decline in Patients Undergoing Neoadjuvant Therapy for Localized Pancreatic Head Adenocarcinoma
    Alessandro Paniccia, Ana Gleisner, Mazen S. Zenati, Amr I. Al Abbas, Jae Pil Jung, Nathan Bahary, Kenneth K.W. Lee, David Christopher Bartlett, Melissa Ellen Hogg, Herbert J. Zeh et al. · 2020 · Annals of Surgical Oncology
  88. Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
    Zimo Zhao, Xinyi He, Yan Sun · 2023 · Frontiers in Pharmacology
  89. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
    Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, Nikolaos Papadopoulos, Sotirios P. Fortis, Vassilis L. Tzounakas, Alkmini T. Anastasiadi, Panagiotis Sarantis, Sofia Vasileiadi, Ariadne Tsagarakis et al. · 2024 · International Journal of Molecular Sciences
  90. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs
    Chenchan Huang, Elizabeth M. Hecht, Erik V. Soloff, Hina Arif Tiwari, Priya Bhosale, Anil Dasayam, Samuel Joseph Galgano, Avinash Kambadakone, Naveen M. Kulkarni, Ott Le et al. · 2024 · American Journal of Roentgenology
  91. The Role of Type 2 Diabetes in Pancreatic Cancer
    Sheeba George, Wilford Jean-Baptiste, Amina Yusuf Ali, Bithaiah Inyang, Feeba Sam Koshy, Kitty George, Prakar Poudel, Roopa Chalasani, Mastiyage R Goonathilake, Sara Waqar et al. · 2022 · Cureus
  92. A Decade Later: Revisiting the TGFβ Family’s Role in Diabetes
    Melissa Brown, Alan L. Schneyer · 2020 · Trends in Endocrinology and Metabolism
  93. Systematic Review of the Integrative Medicine Recommendations for Patients with Pancreatic Cancer
    Andrew A. Gumbs, Manana Gogol, Gaya Spolverato, Heba Taher, Elie K. Chouillard · 2021 · Surgeries
  94. Association between unstable diabetes mellitus and risk of pancreatic cancer
    Sitwat Ali, Michael D Coory, Peter J Donovan, Renhua Na, Nirmala Pandeya, Sallie‐Anne Pearson, Katrina Spilsbury, Louise Maree Stewart, Bridie S. Thompson, Karen Tuesley et al. · 2023 · Pancreatology
  95. Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization
    Te‐Min Ke, Artitaya Lophatananon, Kenneth Ross Muir · 2024 · International Journal of Molecular Sciences
  96. Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer
    Chiara Corradi, Manuel Gentiluomo, Volkan N. Adsay, Juan Sáinz, Paolo Riccardo Camisa, Barbara Włodarczyk, Stefano Crippa, Francesca Tavano, Gabriele Capurso, Daniele Campa · 2024 · Seminars in Cancer Biology
  97. Treatment outcomes with oral anti‐hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population‐based cohort study
    Rhian Hopkins, Katherine Young, Nicholas J Thomas, Angus G. Jones, Andrew Tym Hattersley, Beverley M. Shields, John Dennis, Andrew Peter McGovern · 2025 · Diabetes Obesity and Metabolism
  98. Islet Regeneration and Pancreatic Duct Glands in Human and Experimental Diabetes
    Diletta Overi, Guido Carpino, Marta Moretti, Antonio Franchitto, Lorenzo Nevi, Paolo Onori, Enrico De Smaele, Luca Federici, Daniele Santorelli, Marella Maroder et al. · 2022 · Frontiers in Cell and Developmental Biology
  99. Continuous glucose monitoring to assess glucose variability in type 3c diabetes
    Victoria T. Y. Lee, Ann M. Poynten, Barbara Depczynski · 2022 · Diabetic Medicine
  100. Pancreas and Adverse Drug Reactions: A Literature Review
    Konrad Sosnowski, Piotr Nehring, Adam M. Przybyłkowski · 2022 · Drug Safety